The association of health-care use and hepatitis C virus infection in a random sample of urban slum community residents in Southern India

American Journal of Tropical Medicine and Hygiene

Volumn 68, Issue 2, 2003, Pages 258-262

  Marx, Melissa A ^a   Murugavel, K G ^b   Sivaram, Sudha ^c   Balakrishnan, P ^b   Steinhoff, Mark ^c   Anand, S ^b   Thomas, David L ^d   Solomon, Suniti ^b   Celentano, David D ^c  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEVELOPING COUNTRY; FEMALE; HEALTH CARE UTILIZATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INDIA; INJECTION; INTERVIEW; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEEDLE; POVERTY; PREVALENCE; RISK FACTOR; SEX RATIO; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; STATISTICAL ANALYSIS; URBAN POPULATION; VIRAL CONTAMINATION; ADOLESCENT; DISEASE TRANSMISSION; HEALTH; QUACKERY; SOCIOECONOMICS; STATISTICS;

HEPATITIS C VIRUS;

ADOLESCENT; ADULT; FEMALE; HEPATITIS C; HUMANS; INDIA; MALE; POVERTY; PREVALENCE; QUACKERY; SOCIOECONOMIC FACTORS; URBAN HEALTH;

EID: 0037317829     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2003.68.258     Document Type: Article

References (33)

1. Cardoso MS, Koerner K, Epple S, Dengler T, Kerowgan M, Kubanek B, 1996. HCV transmission through blood transfusion: are HCV-RNA titer in donor serum and genotype major determinants of infection outcome? Beitr Infusionsther Transfusionsmed 33: 225-230.
2. Comandini UV, Tossini G, Longo MA, Ferri F, Cuzzi G, Noto P, Zaccarelli M, Visco G, 1998. Sporadic hepatitis C virus infection: a case-control study of transmission routes in a selected hospital sample of the general population in Italy. Scand J Infect Dis 30: 11-15.
3. Esteban JI, Gomez J, Martell M, Cabot B, Quer J, Camps J, Gonzalez A, Otero T, Moya A, Esteban R, Guardia J, 1996. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 334: 555-560.
4. Forns X, Fernandez-Llama P, Pons M, Costa J, Ampurdanes S, Lopez-Labrador FX, Olmedo E, Lopez-Pedret J, Darnell A, Revert L, Sanchez-Tapias JM, Rodes J, 1997. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit. Nephrol Dial Transplant 12: 736-740.
5. Izopet J, Pasquier C, Sandres K, Puel J, Rostaing L, 1999. Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit. J Med Virol 58: 139-144.
6. Natov SN, Lau JY, Bouthot BA, Murthy BV, Ruthazer R, Schmid CH, Levey AS, Pereira BJ, 1998. Serologic and virologic profiles of hepatitis C infection in renal transplant candidates. New England Organ Bank Hepatitis C Study Group. Am J Kidney Dis 31: 920-927.
7. Donahue JG, Munoz A, Ness PM, Brown DE Jr., Yawn DH, McAllister HA Jr., Reitz BA, Nelson KE, 1992. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327: 369-373.
8. Klein HG, 2000. Will blood transfusion ever be safe enough? JAMA 284: 238-240.
9. Moriya T, Koyama T, Tanaka J, Mishiro S, Yoshizawa H, 1999. Epidemiology of hepatitis C virus in Japan. Intervirology 42: 153-158.
10. Crofts N, Jolley D, Kaldor J, van Beek I, Wodak A, 1997. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Community Health 51: 692-697.
11. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE, 1996. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T- lymphotropic viruses. Am J Public Health 86: 655-661.
12. Smyth BP, Keenan E, O'Connor JJ, 1998. Bloodborne viral infection in Irish injecting drug users. Addiction 93: 1649-1656.
13. Kumar MS, Mudaliar S, Daniels D, 1998. Community-based outreach HIV intervention for street-recruited drug users in Madras, India. Public Health Rep 113 Suppl 1: 58-66.
14. Saha MK, Chakrabarti S, Panda S, Naik TN, Manna B, Chatterjee A, Detels R, Bhattacharya SK, 2000. Prevalence of HCV & HBV infection amongst HIV seropositive intravenous drug users & their non-injecting wives in Manipur, India. Indian J Med Res 111: 37-39.
15. Shrestha SM, Shrestha DM, Gafney TE, Maharjan KG, Tsuda F, Okamoto H, 1996. Hepatitis B and C infection among drug abusers in Nepal. Trop Gastroenterol 17: 212-213.
16. Kao JH, Chen DS, 2000. Transmission of hepatitis C virus in Asia: past and present perspectives. J Gastroenterol Hepatol 15 Suppl: E91-E96.
17. Reeler AV, 1990. Injections: a fatal attraction? Soc Sci Med 31: 1119-11125.
18. Reeler AV, 2000. Anthropological perspectives on injections: a review. Bull World Health Organ 78: 135-143.
19. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M, 1999. Unsafe injections in the developing world and transmission of blood-borne pathogens: a review. Bull World Health Organ 77: 789-800.
20. Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S, Mirza S, Malik T, Fisher-Hoch S, McCormick JB, 2000. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ 78: 956-963.
21. Singh J, Bhatia R, Gandhi JC, Kaswekar AP, Khare S, Patel SB, Oza VB, Jain DC, Sokhey J, 1998. Outbreak of viral hepatitis B in a rural community in India linked to inadequately sterilized needles and syringes. Bull World Health Organ 76: 93-98.
22. Hutin YJ, Harpaz R, Drobeniuc J, Melnic A, Ray C, Favorov M, Iarovoi P, Shapiro CN, Woodruff BA, 1999. Injections given in healthcare settings as a major source of acute hepatitis B in Moldova. Int J Epidemiol 28: 782-786.
23. Kane M, 1998. Unsafe injections. Bull World Health Organ 76: 99-100.
24. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M, 1999. Transmission of hepatitis B, hepatitis C, and human immunodefficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Organ 77: 801-807.
25. Pasha O, Luby SP, Khan AJ, Shah SA, McCormick JB, Fisher-Hoch SP, 1999. Household members of hepatitis C virus-infected people in Hafizabad, Pakistan: infection by injections from health care providers. Epidemiol Infect 123: 515-518.
26. Luby SP, Qamruddin K, Shah AA, Omair A, Pahsa O, Khan AJ, McCormick JB, Hoodbhouy F, Fisher-Hoch S, 1997. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect 119: 349-356.
27. Huraib S, al-Rashed R, Aldrees A, Aljefry M, Arif M, al-Faleh FA, 1995. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol Dial Transplant 10: 470-474.
28. Michel JM, 1985. Why do people like medicines? A perspective from Africa. Lancet 1: 210-211.
29. Vishnu-Priya S, Lee C, 2001. Injection Practices in Tamil Nadu, Rapid Assessment and Proposed Plan of Action, January 2001. Geneva: World Health Organization.
30. Lakshman M, Nichter M, 2000. Contamination of medicine injection paraphernalia used by registered medical practitioners in south India: an ethnographic study. Soc Sci Med 51: 11-28.
31. Singh J, Gupta S, Khare S, Bhatia R, Jain DC, Sokhey J, 2000. A severe and explosive outbreak of hepatitis B in a rural population in Sirsa district, Haryana, India: unnecessary therapeutic injections were a major risk factor. Epidemiol Infect 125: 693-699.
32. Anand K, Pandav CS, Kapoor SK, 2001. Injection use in a village in north India. Natl Med J India 14: 143-144.
33. Shev S, Hermodsson S, Lindholm A, Malm E, Widell A, Norkrans G, 1995. Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors-the role of parenteral and sexual transmission. Scand J Infect Dis 27: 99-104.